Are you attending the 10th annual national conference of the Swedish Health Economics Association (SHEA) in Gothenburg this week? In that case we really hope that you were able to listen in on Quantify’s Douglas Knutsson yesterday when […]
The poster “Clinical Outcomes in People With Cystic Fibrosis Treated With Lumacaftor/Ivacaftor in Routine Clinical Practice in Sweden”, co-authored by Quantify’s Martina Aldvén, Jonas Banefelt and Fredrik Borgström was […]
An abstract co-authored by Quantify’s Emilie Toresson Grip, has been accepted for oral presentation at the European Society of Cardiology Heart Failure 2021 Online Congress in June. For this […]
We hope that you did not miss our contribution to the multi-country CEA regarding COPD (Chronic Obstructive Pulmonary Disease) during ISPOR. Click here to see the full poster.
We are happy to announce that Quantify’s Trolle Jacobson and Thomas Fast has presented Q-PARK, one of our research platforms at ISPOR. With Q-PARK, it is possible to analyze switches and HCRU for patients with Parkinson´s disease. See the full […]
QUANTIFY’s CEO Kirk Geale will be presenting an on-demand session titled “Nordic Decision-Making: Real-World Data and HTA” at the 2020 Canadian Agency for Drugs and Technologies in Health (CADTH) symposium, […]
Anders Gustavsson, Partner at Quantify, is a panelist at a HTAi symposium on the value of delaying progression in early Alzheimer’s disease on October 13, sponsored by Biogen.
See full program on https://htai.eventsair.com/htaibeijing2020/#program.
[…]